Influence of apolipoprotein A-1 promoter polymorphism on lipid levels and responses to dietary change in Finnish adults

Journal of Internal Medicine

Volumn 241, Issue 5, 1997, Pages 373-378

  Meng, Qing He ^a   Pajukanta, P ^a   Valsta, L ^b   Aro, A ^b   Pietinen, P ^b   Tikkanen, M J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

apolipoprotein A 1 gene promoter polymorphism; HDL high density lipoprotein cholesterol; low fat diet; plasma lipids

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0030908611     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.122139000.x     Document Type: Article

References (37)

1. Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromso heart study. High density lipoprotein and coronary heart disease: A prospective case-control study. Lancet 1977; i: 965-8.
2. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: The Framingham study. Am J Med 1977; 62: 707-14.
3. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991; 325: 373-81.
4. Reichl D, Miller NE. Pathophysiology of reverse cholesterol transport: Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 1989; 9: 785-97.
5. Knuiman JT, West CE, Katan MB, Hautvast JGAT. Total cholesterol and high density cholesterol levels in populations differing in fat and carbohydrate intake. Arteriosclerosis 1987; 7: 612-19.
6. Berg K, Borresen A-L, Dahlen G. Effect of smoking on serum levels of HDL apolipoproteins. Atherosclerosis 1979; 34: 339-43.
7. Tikkanen MJ. Role of plasma lipoproteins in the pathogenesis of atherosclerotic disease, with special reference to sex hormone effects. Am J Obstet Gynecol 1990; 163: 296-304.
8. Ohta T, Hattori S, Murakami M, Nishiyuama S, Matsuda I. Age- and sex-related differences in lipoproteins containing apoprotein A-I. Arterosclerosis 1989; 9: 90-95.
9. Haffner SM, Applebaum-Bowden D, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Hazzard WR. Epidemiological correlates of high density lipoprotein subfractions, apolipoprotein AI, AII and D and lecithin cholesterol acyltransferase: Effects of smoking, alcohol and adiposity. Arteriosclerosis 1985; 5: 169-77.
10. Sigurdsson GJr, Gudnason V, Sigurdsson G, Humphries SE. Interaction between a polymorphism of the apolipoprotein AI promote region and smoking determines plasma high levels of HDL and ApoA-I. Arteroscler Thromb 1992; 12: 1017-22.
11. Kuusi T, Kesaniemi YA, Vuoristo M, Miettinen TA, Koskenvuo M. Inheritance of high density lipoprotein lipase and hepatic lipase activity. Arteriosclerosis 1987; 7: 421-5.
12. Moll PP, Michels VV, Weidman WH, Kottke BA. Genetic determination of plasma apolipoprotein AI in a population-based sample. Am J Hum Genet 1989; 44: 124-39.
13. Jeenah M, Kessling A, Miller N, Humphries SE. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 1990; 7: 233-11.
14. Paul-Hayase H, Rosseneu M, Robinson D, Van Bervliet JP, Deslypere JP, Humphries SE. Polymorphisms in the apolipoprotein(apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apoAI. apoCIII and apoAIV concentrations. Hum Genet 1992; 88: 439-46.
15. Xu C-F, Angelico F, DelBen M, Humphries SE. Role of genetic variation at the apoAI-CIII-AIV gene cluster in determining plasma apoAI levels in boys and girls. Genet Epidemiol 1993; 10: 113-22.
16. Saha N, Tay JSH, Low PS, Humphries SE. Guanidine to adenine(G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genet Epidemiol 1994; 11: 255-64.
17. Pagani F, Sidoli A, Giudici GA, Barenghi L, Vergani C, Baralle FE. Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J Lipid Res 1990; 31: 1371-7.
18. Talmud PJ, Ye S, Humphries SE. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study. Genet Epidemiol. 1994; 11: 265-80.
19. Minnich A, DeLangavant G, Lavigne J, Roederer G, Lussier-Cacan S, Davignon J. G → A substitution at position - 75 of the apolipoprotein A-I gene promoter: Evidence against a direct effect on HDL cholesterol levels. Arterioscler Thromb Vasc Biol. 1995; 15: 1740-5.
20. Smith JD, Brinton EA, Breslow JL. Polymorphism in the human apolipoprotein A-I gene promoter region : association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest 1992; 89: 1796-1800.
21. Civeira F, Pocovi M, Cenarro A, Garces C, Ordovas JM. Adenine for guanine substitution - 78 base pairs 5′ to the apolipoprotein (APO)A-I gene: relation with high density lipoprotein cholesterol and Apo A-I concentrations. Clin Genet 1993; 44: 307-12.
22. Barre DE, Guerra R, Verstraete R, Wang Z, Grundy SM, Cohen JC. Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levels. J Lipid Res. 1994; 35: 1292-6.
23. Lopes-Miranda J, Ordovas JM, Espino A, Marin C, Salas J. Lopez-Segura F et al. Influence of mutation in human apolipoprotein A-I gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 1994; 343: 1246-9.
24. Pajukanta PE, Valsta LM, Aro AV, Pietinen P, Heliö T, Tikkanen MJ. The effects of the apolipoprotein B signal peptide (ins/del) and Xbal polymorphisms on plasma lipid responses to dietary change. Atherosclerosis 1996; 122: 1-10.
25. Kostner GM. Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 1976; 22: 695.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
27. Huttunen JK, Länsimies E, Ehnholm C, Hietanen E. Penttilä I, Siitonen O, Rauramaa R. Effect of moderate physical exercise on serum lipoproteins: a controlled clinical trial with special reference to serum high-density lipoprotein. Circulation 1979; 60: 1220-9.
28. Kunkel LM, Smith KD, Bayer SH, Borgoankar DS, Wachtel SO, Miller OE et al. Analysis of human Y-chromosome specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977; 74: 1245-9.
29. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91.
30. Machin D, Campbell MJ. Statistical Tables for the Design of Clinical Trials, 1st edn. Oxford: Blackwell Scientific Publications. 1987.
31. Jeenah MS, Wells C. Functional significance of a point mutation in the apoA-I promoter (Abstract). Circulation (suppl) 1992; 86: i-279.
32. Angotti E, Mele E, Costanzo F, Avvedimento EV. A polymorphism (G → A transition) in the - 78 position of the apolipoprotein A-I promoter increases transcription efficiency. J Bio Chem 1994; 269: 17 371-4.
33. Tuteja R, Tuteja N, Melo C, Casari G, Baralle FE. Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition . FEBS Lett 1992; 304: 98-101.
34. 4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 1990; 10: 285-8.
35. Tikkanen MJ, Xu C-F, Hämäläinen T, Talmud P, Sarna S, Huttunen JK, Pietinen P, Humphries SE. Xbal polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clin Genet 1990; 37: 327-34.
36. Lopez-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Judd TJ, Schaefer EJ. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J. Lipid Res 1994; 35: 1965-75.
37. Katan MB, Beynen AC, De Vries JHM, Nobels A. Existence of consistent hypo- and hyperresponders to dietary cholesterol in man. Am J Epidemiol. 1986; 123: 221-34.